Učitavanje...
IL13Rα2 is a novel therapeutic target for human adrenocortical carcinoma
BACKGROUND: Adrenocortical carcinoma (ACC) is a relatively rare but aggressive malignancy with limited therapeutic options. Previous genome wide expression studies have shown overexpression of Interleukin-13 receptor alpha2 (IL13Rα2) in some human malignancies. METHODS: We evaluated IL13Rα2 mRNA and...
Spremljeno u:
| Glavni autori: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2012
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3416952/ https://ncbi.nlm.nih.gov/pubmed/22570059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27629 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|